#VisualAbstract: Pridopidine Does Not Impact the Progression of Amyotrophic Lateral Sclerosis
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In this scoping review, qualitative studies on amyotrophic lateral sclerosis (ALS) demonstrated a perceived benefit of spirituality on outcomes ...
Spirituality has mixed effects on outcomes in ALS patients and caregivers 1. In this scoping review, qualitative studies on amyotrophic ...
1. In patients with amyotrophic lateral sclerosis (ALS) and superoxide dismutase 1 (SOD1) mutations, tofersen does not result in significant ...
1. De novo variants in the SPTLC1 gene among unrelated patients were associated with juvenile amyotrophic lateral sclerosis using exome ...
Association between neuraxial anaesthesia or general anaesthesia for lower limb revascularisation surgery in adults and clinical outcomes: population based comparative ...
1. Sodium phenylbutyrate-taurursodiol slowed the functional decline in patients with amyotrophic lateral sclerosis. 2. The mean rate of change for ...
1. A 100mg treatment of tofersen was shown to decrease cerebrospinal fluid (CSF) superoxide dismutase 1 (SOD1) concentration in adults ...
Originally published by Harvard Health. What Is It? Amyotrophic lateral sclerosis (ALS) causes a slow degeneration of nerve cells that ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.